APRE: $30 from $15 | a risk free deal

Updated
ahead of the curve going all in
Note
it came back to where it started and even way lower
and reversed backed.

cycle
Beyond Technical AnalysisbiotechcoronaCoronavirus (COVID-19)novelpharmaceuticals

Disclaimer